What Is a GLP-1 Medication? The Complete Overview
Modern Weight Science Editorial Team
Editorial Team
GLP-1 medications have become the most talked-about drugs in weight management — but what exactly are they, who are they for, and how do they fit into a broader treatment plan?
GLP-1 medications — short for glucagon-like peptide-1 receptor agonists — are a class of injectable (and increasingly oral) drugs that mimic a hormone your gut naturally releases after eating. Over the past decade they have transformed the treatment of type 2 diabetes, and in recent years they have produced some of the most significant weight loss results ever seen in pharmaceutical trials.
What the medication class actually includes
Not all GLP-1 medications are the same drug. The class includes several distinct molecules approved for different indications:
- Semaglutide — available as Ozempic (diabetes), Wegovy (weight management), and Rybelsus (oral diabetes)
- Tirzepatide — available as Mounjaro (diabetes) and Zepbound (weight management); a dual GLP-1/GIP agonist
- Liraglutide — available as Victoza (diabetes) and Saxenda (weight management); an older daily injection
- Dulaglutide — Trulicity; weekly injection approved for diabetes
When most people say "GLP-1 medication" they are referring to semaglutide or tirzepatide, which have dominated the market due to their efficacy and weekly dosing.
How they work
All GLP-1 medications activate the GLP-1 receptor, which does several things simultaneously: it stimulates insulin release in response to blood sugar, suppresses the glucagon signal that drives blood sugar up, slows how quickly food leaves your stomach, and — critically for weight management — acts on appetite-regulation centres in the brain to reduce hunger and food preoccupation.
Who they are approved for
FDA approval criteria differ by drug and indication. As a general guide:
- Type 2 diabetes: Ozempic, Mounjaro, Trulicity, Victoza — typically prescribed when diet and lifestyle alone are insufficient
- Weight management: Wegovy (BMI ≥30, or ≥27 with a weight-related condition) and Zepbound (same criteria)
Insurance coverage and prescriber practice vary. Some providers prescribe diabetes-approved formulations off-label for weight management when weight-specific drugs are unavailable or unaffordable.
What they are not
GLP-1 medications reduce appetite and make weight loss easier — they do not do the work for you. Protein intake, resistance training, and building sustainable eating habits matter enormously alongside the medication. They also do not produce permanent changes: for most people, some weight returns after stopping, which is why long-term planning matters from day one.
This is educational content, not medical advice. Whether a GLP-1 medication is appropriate for you is a decision to make with a licensed clinician who knows your full history.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Content reviewed against peer-reviewed research. Read our editorial policy →
Last updated May 2026
Frequently Asked Questions
What is GLP-1 and how does it work?
GLP-1 (glucagon-like peptide-1) is a hormone released by intestinal L-cells after eating. It stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and activates hypothalamic satiety pathways to reduce appetite. GLP-1 receptor agonist medications mimic these effects with a much longer duration — typically one week per injection.
How do GLP-1 medications cause weight loss?
GLP-1 receptor agonists reduce appetite through two pathways: peripheral (slowing gastric emptying extends fullness) and central (activating hypothalamic and brainstem receptors reduces hunger signaling and 'food noise'). The result is a sustained reduction in calorie intake without requiring active willpower against elevated hunger hormones.
What is the difference between semaglutide and tirzepatide?
Semaglutide (Ozempic, Wegovy) activates GLP-1 receptors only. Tirzepatide (Mounjaro, Zepbound) is a dual GLP-1/GIP agonist. Clinical trials show tirzepatide produces higher average weight loss (~20-22% in SURMOUNT-1 vs. ~15% for semaglutide in STEP 1), though individual response varies considerably depending on biology, dose, and adherence.
Are GLP-1 medications safe to use long-term?
The longest available randomized trial data (STEP 5 for semaglutide) shows maintained efficacy and tolerability over two years. Side effects are primarily gastrointestinal and concentrated during dose escalation. As with any prescription medication, long-term risks and benefits must be evaluated with a licensed clinician who knows your individual medical history.
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.
Explore Modern GLP-1 Approaches
Telehealth platforms that connect patients with licensed clinicians to evaluate GLP-1 based care.
Ro Body
Licensed physicians review your medical history, discuss GLP-1 receptor agonist options, and provide ongoing monitoring — all remotely.
Explore approachHims & Hers
Connects patients with licensed clinicians who specialize in metabolic care, including evaluation for GLP-1 medications where appropriate.
Explore approachPlushCare
Board-certified physicians available for metabolic health consultations, with the ability to prescribe and monitor evidence-based treatments.
Explore approachAffiliate disclosure: Modern Weight Science may earn a commission if you visit or purchase through these links, at no additional cost to you. Programs are listed for educational relevance. This is not a clinical recommendation — always consult a licensed healthcare professional before starting any treatment.
Weekly Digest
Get Evidence-Based Metabolic Health Insights Weekly
Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.
Continue reading
Related articles
What Is GLP-1? A Plain-Language Guide to How These Medications Work
GLP-1 stands for glucagon-like peptide-1 — a hormone your gut produces naturally after every meal. Understanding what it does, and how medications mimic it, explains almost everything about why these drugs work.
Sleep Quality on Semaglutide: What Patients Report
Better sleep is among the most-reported quality-of-life changes on semaglutide. Some of it is weight-mediated; some of it appears to be direct.
Foods to Avoid on GLP-1 Medications (and Why They Trigger Side Effects)
Slowed gastric emptying makes some foods feel worse than others. The list isn't long, but it's specific.
Not Losing Weight on Ozempic? 7 Reasons and What to Try
STEP 1 average: 14.9% loss at 68 weeks. But the range was wide — some lost over 25%, some less than 5%. Here are the most common explanations for being on the lower end of that distribution.